|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1156 15TH STREET, NW, #700 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 26422-24
|
||||||||
|
6. House ID# 302590000
|
||||||||
| TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Nicole McFarland |
Date | 10/14/2016 3:14:24 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Gender equality and reproductive freedom;
H.R.2802, the First Amendment Defense Act, regarding refusal laws and discrimination against women and LGBT individuals;
H.R.4824, Conscience Protection Act, regarding the Federal Refusal Clause/Weldon amendment;
S.2943, National Defense Authorization Act, regarding discrimination against women and LGBT individuals;
S.Res.530, terminating Select Investigative Panel on Infant Lives;
House Energy and Commerce Committee Forum on Protecting Conscience Rights, regarding the Federal Refusal Clause/Weldon amendment;
House Committee on Oversight and Government Reform hearing on H.R.2802, the First Amendment Defense Act, regarding refusal laws and discrimination against women and LGBT individuals;
House Judiciary Subcommittee on the Constitution and Civil Justice hearing on the Hyde amendment and H.R.3504, the Born-Alive Abortion Survivors Protection Act;
Senate Foreign Relations Subcommittee on the Western Hemisphere hearing on risks of and responses to Zika, regarding family-planning funding;
House Select Investigative Panel on Infant Lives vote on StemExpress criminal contempt citation, regarding privacy for StemExpress employees;
Affordable Care Act contraceptive-coverage policy, regarding exemptions for non-profit organizations;
Title X regulations, regarding family-planning services.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), White House Office, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Crane |
|
|
|
Leslie |
McGorman |
|
|
|
Kate |
Ryan |
|
|
|
Leslie |
Powell |
|
|
|
Nicole |
McFarland |
|
|
|
Kyra |
Berasi |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Nomination of Merrick Garland to the Supreme Court.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Crane |
|
|
|
Leslie |
Powell |
|
|
|
Kate |
Ryan |
|
|
|
Leslie |
McGorman |
|
|
|
Nicole |
McFarland |
|
|
|
Kyra |
Berasi |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S.3117/ H.R.2772, FY17 State and Foreign Operations appropriations bill, regarding international family-planning funding, the United Nations Population Fund, and the global gag rule;
S.3040/H.R.5926, FY17 Labor, Health and Human Services, and Education appropriations bill, regarding sex-education and abstinence-only funding, the Federal Refusal Clause/Weldon amendment, defunding the Affordable Care Act, Title X family-planning funding, and the Hyde amendment;
H.R.2577, FY17 Military Construction - VA Appropriations and Zika Supplemental, regarding funding for family planning;
H.R.5325, FY17 Legislative Branch Appropriations Act, regarding a continuing-resolution package and Zika-response funding;
Palmer amendment to H.R.5485, Financial Services and General Government Appropriations Act, regarding the D.C. Reproductive Health Non-Discrimination Amendment Act, prohibiting employers from firing employees for their reproductive-health decisions;
Grayson amendment to H.R.5485, Financial Services and General Government Appropriations Act, regarding abortion coverage for federal employees.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Crane |
|
|
|
Leslie |
McGorman |
|
|
|
Leslie |
Powell |
|
|
|
Kate |
Ryan |
|
|
|
Nicole |
McFarland |
|
|
|
Kyra |
Berasi |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |